GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1051 - 1075** of **4050** in total

« First

‹ Prev

…

39

40

41

42

43

44

45

46

47

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgG	Patient 3	4	mild	G10133VD	63
IgG	Patient 1	10	moderate	G14569AR	64
IgM	Patient 1	22	moderate	G68461PT	64
IgG	Patient 2	15	mild	G91237TK	64
IgG	Patient 2	24	mild	G73271MD	64
IgM	Patient 2	24	mild	G32611KT	64
IgM	Patient 1	6	moderate	G25559RS	64
IgG	Patient 3	-180	mild	G39023AU	64
IgG	Patient 3	11	mild	G02557XE	64
IgM	Patient 3	-180	mild	G21320TF	64
IgM	Patient 3	-180	mild	G63074CQ	64
IgM	Patient 3	-180	mild	G82942ZJ	64
IgM	Patient 3	-180	mild	G86541PE	64
IgG	Patient 3	11	mild	G47566FL	64
IgG	Patient 1	22	moderate	G81315DD	65
IgM	Patient 1	10	moderate	G49916XD	65
IgM	Patient 1	10	moderate	G67045LB	65
IgM	Patient 1	22	moderate	G25473LQ	65
IgG	Patient 2	24	mild	G82096UQ	65
IgG	Patient 3	-180	mild	G96881BQ	65
IgG	Patient 3	11	mild	G36191CD	65
IgG	Patient 3	11	mild	G48898TH	65
IgG	Patient 3	4	mild	G47566FL	65
IgM	Patient 3	11	mild	G32473MI	65
IgM	Patient 1	10	moderate	G10133VD	66